Literature DB >> 2539639

Antigenic relationship among strains of ibaraki virus and epizootic haemorrhagic disease virus studied with monoclonal antibodies.

M Sugiyama1, N Hirayama, H Sasaki, T Sugimura, N Minamoto, T Kinjo.   

Abstract

Twelve monoclonal antibodies against ibaraki virus (IbV) were established and preliminarily characterised by indirect immunoperoxidase (IIP), haemagglutination inhibition (HI) and neutralisation (NT) tests. Five antibodies reacted in the IIP test with all IbV and epizootic haemorrhagic disease virus (EHDV) strains tested, and five antibodies reacted with IbV and Alberta strain (serotype 2) but not with New Jersey strain (serotype 1) of EHDV. Two of 12 antibodies showed both HI and NT activities. Viral proteins with molecular weights of about 24,000 daltons (24KD) and 78KD were determined by two monoclonal antibodies in Western blot analysis. One of two antibodies with the ability of both HI and NT recognised a viral protein with a molecular weight of about 78KD.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2539639

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  4 in total

1.  Identification and PCR-restriction fragment length polymorphism analysis of a variant of the Ibaraki virus from naturally infected cattle and aborted fetuses in Japan.

Authors:  S Ohashi; K Yoshida; Y Watanabe; T Tsuda
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

2.  Analysis of intratypic variation evident in an Ibaraki virus strain and its epizootic hemorrhagic disease virus serogroup.

Authors:  Seiichi Ohashi; Kazuo Yoshida; Tohru Yanase; Tomoyuki Tsuda
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

3.  Duplex Real-Time RT-PCR Assays for the Detection and Typing of Epizootic Haemorrhagic Disease Virus.

Authors:  Cyril Viarouge; Emmanuel Breard; Stephan Zientara; Damien Vitour; Corinne Sailleau
Journal:  PLoS One       Date:  2015-07-10       Impact factor: 3.240

4.  Development of reverse genetics for Ibaraki virus to produce viable VP6-tagged IBAV.

Authors:  Eiko Matsuo; Keiichi Saeki; Polly Roy; Junichi Kawano
Journal:  FEBS Open Bio       Date:  2015-05-27       Impact factor: 2.693

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.